Regenerative Chiropractic Care for Musculoskeletal Pain Relief

Regenerative Chiropractic Care for Musculoskeletal Pain: My Clinical Framework and Collaborative Model in El Paso, Texas

Abstract

In this educational post, I share how I approach common musculoskeletal conditions using modern orthobiologics, integrative chiropractic care, and rehabilitation within a multidisciplinary practice in El Paso, Texas. I outline evidence-supported indications for platelet-rich plasma (PRP), microfragmented adipose tissue (MFAT), percutaneous tenotomy, and structured rehab for partial-thickness tendon tears, rotator cuff pathology, elbow tendinopathies, hip and knee osteoarthritis (OA), gluteal and hamstring tendinopathies, plantar fasciitis, and meniscal microtears. I present a practical algorithm for knee OA that integrates systemic health, imaging, and response timelines. I also discuss recent machine-learning work examining predictors of PRP response, highlighting physiologic variables such as joint osmotic pressure, lipoprotein(a), and uric acid. Finally, I detail how integrative chiropractic care fits into these treatment pathways and introduce our collaborative medical oversight by Dr. Maria Guadalupe Cardenas, MD, who will serve as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic). Together, we blend internal medicine, functional medicine, chiropractic, personal injury care, and rehab to deliver precise, patient-centered outcomes.

About Our Collaborative Model and Me

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. My clinical work focuses on integrative injury care, functional medicine, and evidence-based musculoskeletal management. In El Paso, Texas, our practice, Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), is evolving to incorporate a robust multidisciplinary framework to ensure medical oversight and precision in safety.

• Medical Director and Collaborative Physician: Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), with over 40 years of experience as an internist, will serve as the Medical Director and Collaborative Physician alongside me. This integrative model—an MD providing medical direction with a chiropractor delivering conservative and rehabilitative care—is common in injury and functional care clinics and improves coordination, safety, and outcomes.
• Integrative Care Pillars:
  • Internal Medicine Oversight (Dr. Cardenas): systemic risk evaluation; medication safety; lab interpretation; cardiometabolic assessment; medical triage and referrals.
  • Chiropractic and Rehabilitation (Dr. Jimenez): biomechanical assessment; manual therapy; spinal and extremity adjustments; neuromuscular re-education; kinetic-chain rehab; return-to-function plans.
  • Functional Medicine: root-cause analysis; inflammatory load reduction; nutrition and sleep optimization; microbiome and hormonal assessments.
  • Personal Injury Care: comprehensive documentation; objective functional recovery; medico-legal clarity; imaging coordination.
  • Orthobiologics: PRP, MFAT consideration in select cases; ultrasound-guided injections; percutaneous tenotomy; post-procedure rehab design.
  • Imaging and Technology: musculoskeletal ultrasound, MRI correlation; digital functional metrics; health tech data streams to stratify risk and predict response.

Why Evidence Matters in Our Setting

El Paso has a diverse patient population, and my clinical practice has long been driven by evidence-based protocols. My approach matured during time working near high-research environments where every plan had to withstand scrutiny. In my orthopedic collaborations, we formed condition cohorts for which the literature supports nonoperative orthobiologic and rehabilitative strategies. This mindset influences our protocols at Injury Medical Clinic PA today.

Key Indications We Consider for Orthobiologics and Integrative Care

• Shoulder:
  • Low-grade partial-thickness rotator cuff tears (often ≤50% thickness).
  • Mild-to-moderate glenohumeral OA, assessed with Walch classification to ensure the humeral head’s congruency and avoid severe posterior wear and decentering.
  • Subacromial bursitis and interstitial tendon lesions where targeted delivery is feasible.
• Elbow:
  • Lateral epicondylalgia (tennis elbow) and medial epicondylalgia (golfer’s elbow), especially with ultrasound-confirmed common extensor/flexor tendinosis or partial-width defects.
  • UCL proximal partial tears in selected athletes with stability preserved.
• Hand/Wrist:
  • CMC joint OA at the thumb base; evidence suggests biologics plus structured stabilization and manual therapy can reduce pain and improve function.
• Hip:
  • FAI (femoroacetabular impingement) types up to Cam/Pincer grade 2, where labral integrity is compromised but not shredded beyond salvage; targeted rehab and injection strategies can modulate symptoms.
  • Gluteus medius tendinopathy and proximal hamstring tendinopathy, with mid-portion focal tears often responding better to guided tenotomy and PRP.
• Foot/Ankle:
  • Plantar fasciitis, especially recalcitrant cases with sonographic thickening and hypoechoic changes, can be accelerated by combining load management with orthobiologics to promote tissue repair.
• Knee:
  • Mild-to-moderate knee OA with preserved joint space; small, stable meniscal tears without mechanical locking; patellar tendinopathy with partial-thickness defects.

How We Visualize and Treat Partial-Thickness Tears

When I evaluate tendons via ultrasound, I map lesions in both short-axis and long-axis to capture the full length and width of the tear. In my hands, outcomes improve when I treat the entire lesion footprint rather than a single focal point. I use fluid tracking during guided procedures to confirm that the injectate reaches the entire defect, promoting a uniform biologic response.

• Why this works:
  • Partial-thickness tears often harbor degenerative collagen disorganization and hypovascular zones. PRP delivers growth factors (PDGF, TGF-β, VEGF) that stimulate tenocyte proliferation and collagen type I remodeling.
  • Covering the full footprint reduces the risk of untreated degenerate tissue continuing to propagate microtears under load.
• Clinical observation:
  • Over years of implementation, I’ve found that interstitial tears adjacent to the rotator cable—particularly near the biceps tendon—may respond less predictably because injectate dispersal and mechanical shear from biceps excursion can reduce localized graft retention. Lesions slightly farther from that dynamic region often show better localization and outcomes.

Orthobiologic Decision Points: PRP vs Microfragmented Adipose Tissue (MFAT)

• Low-grade partial-thickness tears (≤50% thickness):
  • I generally consider PRP or PRP plus hyaluronic acid (HA) in select joints to synergize lubrication with biologic signaling.
  • Rationale: PRP is anti-inflammatory and pro-regenerative, suitable for degenerative microdefects where the extracellular matrix (ECM) remains largely intact.
• Higher-grade partial-thickness, partial-width tears (>50% thickness):
  • I may consider MFAT, leveraging adipose-derived microvascular fragments and pericytes to provide a biologic scaffold and paracrine signaling to the disrupted ECM.
  • Rationale: The scaffold-like properties help bridge larger defects, and adipose SVF-associated signals may modulate macrophage phenotypes toward a reparative M2 profile, supporting collagen maturation and neovascularization.
• Arthritis severity:
  • Mild to moderate OA: PRP is often favored for its capacity to modulate synovial inflammation and cartilage catabolism without over-intervention.
  • Moderate to severe OA: I consider MFAT or bone marrow concentrate depending on imaging (subchondral edema, cysts) and systemic factors, recognizing the need for stronger trophic support.
• Percutaneous tenotomy and calcific tendinitis:
  • After ultrasound-guided barbotage or tenotomy, I often add PRP to improve post-procedural pain and expedite tendon remodeling.

Shoulder Rotator Cuff: Targeting the Lesion and the Bursal Environment

Rotator cuff partial-thickness tears frequently coexist with bursitis and interstitial edema. I localize injections to:

• The tear plane itself (black hypoechoic zone under ultrasound).
• The adjacent subacromial-subdeltoid bursa when inflamed, as the bursa can perpetuate pain and restrict function.
• Why treat both:
  • The bursa’s cytokine milieu (IL-1β, TNF-α) perpetuates tendon nociception and edema. Modulating both tendon and bursa yields better pain reduction and mechanical glide during rehab.

Patellar Tendinopathy: Navigating Multiple Pain Generators

In patellar tendinopathy with coexisting knee OA, calcium deposits, or heterogeneous echotexture:

• We assess whether the primary pain generator is the tendon or joint compartment.
• If the tendon exhibits a large partial-thickness tear and palpable focal tenderness, I target the tendon defect with PRP and design a load-progressive rehab plan (from isometrics to eccentrics to heavy, slow resistance).
• If cartilage or subchondral edema predominates in symptoms, joint-directed therapy (PRP/HA and unloading strategies) may take precedence initially.

Physiology and Reasoning:

• Tenocytes respond to mechanotransduction; controlled loading after PRP upregulates collagen-I synthesis and aligns fibers longitudinally.
• Addressing calcium deposits via tenotomy/barbotage removes a chronic irritant that hinders tendon sliding and perpetuates neo-innervation and pain.

A Practical Algorithm for Knee Osteoarthritis

To streamline decisions, I use the following algorithm:

• Step 1: Assess systemic health and healing capacity
  • Identify systemic inflammatory states (metabolic syndrome, autoimmune activity), hormonal insufficiencies, or nutrient deficits.
  • Evaluate microbiome considerations where indicated, as dysbiosis can elevate systemic LPS and joint inflammation.
• Step 2: Grade OA severity
  • If grade 3–4 OA (advanced joint space loss, osteophytes, bone-on-bone features):
    • Consider an MFAT or a structured surgical referral when mechanical failure predominates.
  • If mild-to-moderate OA with preserved congruity:
    • Consider PRP.
• Step 3: Evaluate imaging
  • Subchondral bone edema on MRI suggests high nociceptive drive and mechanical overload; in these cases, PRP alone may be insufficient, and MFAT or marrow-derived options can be discussed.
• Step 4: Set expectations and timeline
  • PRP commonly triggers a transient flare for up to 3 days.
  • Symptomatic improvement often begins at 3–6 weeks.
  • By 12 weeks, I reassess whether we have achieved at least 60% improvement in pain and function; if not, we recalibrate—address systemic drivers, adjust rehab, and consider alternative biologic options.

Recent Machine-Learning Insights: Predicting PRP Responders

Emerging models trained on large datasets have attempted to predict the response to PRP in OA by integrating clinical and laboratory variables. One recent machine-learning study examined multifactorial predictors and highlighted:

• Joint osmotic pressure (reflecting effusion and synovial inflammation) as a key variable; higher baseline effusion often correlates with poorer short-term outcomes.
• Lipoprotein(a) and uric acid as influential systemic markers, possibly reflecting:
  • Lp(a)’s pro-inflammatory vascular effects and atherogenic burden impacting microvascular supply to joint tissues.
  • Uric acid’s role in inflammasome activation (NLRP3) and low-grade synovitis, which can blunt biologic repair signals.

What this means clinically:

• We increasingly check uric acid and lipid profiles (including Lp(a)) when planning PRP for OA, aligning internal medicine oversight with biologic therapy.
• Stratifying by effusion helps set expectations and may guide adjunctive measures (anti-inflammatory strategies, aspiration plus PRP where appropriate).

How Integrative Chiropractic Care Fits Into Orthobiologic Strategies

Integrative chiropractic care is central to recovery. Orthobiologics can initiate tissue repair, but mechanical loading patterns and neuromuscular coordination determine whether repair endures.

• Biomechanical assessment:
  • We analyze regional interdependence: hip mobility affects knee loading; thoracic mobility influences shoulder mechanics.
  • We identify faulty movement patterns that create tendon compression-shear cycles (e.g., scapular dyskinesis causing rotator cuff overload).
• Manual interventions:
  • Joint mobilization and adjustments to optimize arthrokinematics and reduce nociceptive input.
  • Soft-tissue work to release myofascial adhesions and normalize glide around healing tendons.
• Neuromuscular re-education:
  • Proprioceptive training restores joint position sense altered by inflamed synovium and effusion.
  • Progressive eccentrics and heavy-slow resistance rebuild tendon stiffness and energy storage capacity.
  • Gait and kinetic-chain retraining to redistribute loads away from vulnerable tissues.
• Why this matters physiologically:
  • Tendons are mechanoresponsive; the alignment of collagen fibrils and the ratio of type I to III collagen depend on controlled strain.
  • Cartilage and subchondral bone respond to intermittent compression, thereby enhancing osteochondral perfusion and synovial fluid turnover.

Collaborative Care: Internal Medicine Oversight Enhances Safety and Precision

With Dr. Cardenas guiding medical decisions:

• We screen for medication interactions (e.g., anticoagulation affecting injection risk, NSAIDs modulating PRP efficacy via platelet function).
• We address cardiometabolic risks that impair microvascular support to joint tissues.
• We interpret and act on lab markers (e.g., uric acid, Lp(a), hsCRP) that may shift prognosis and therapy choice.

Functional Medicine: Reducing Inflammatory Load and Optimizing Recovery

My functional medicine training drives attention to:

• Nutrition: adequate protein for collagen synthesis; anti-inflammatory diet patterns; micronutrients (vitamin D, magnesium).
• Sleep and stress modulation: cortisol rhythm impacts tissue repair and pain perception.
• Microbiome and gut permeability: targeted strategies reduce systemic immune activation that can hinder joint recovery.

Personal Injury Care: Documentation and Outcome Pathways

In injury cases:

• We integrate imaging, objective functional measures, and clear return-to-work and return-to-sport milestones.
• We provide structured rehab timelines aligned with tissue-healing phases (inflammatory, proliferative, remodeling), updating expectations at defined checkpoints (3, 6, 12 weeks).

Ultrasound-Guided Precision: Technical Pearls I Use

• Map lesions thoroughly in short- and long-axis to determine full defect size.
• Use hydrodissection or fluid confirmation to verify that the injectate spreads across the lesion footprint.
• Treat adjacent bursal inflammation when it drives symptoms, and avoid dispersing injectate into regions where dynamic tendon movement could displace the biologic (e.g., near the biceps groove).

Rotator Cable Considerations: Why Lesion Location Matters

• The rotator cable is a thickened band that transmits loads across the cuff; tears near this structure experience distinct mechanical environments.
• Biceps tendon excursions can shear and redistribute injectate, reducing dwell time at the target lesion.
• Practical implication: when feasible, I optimize injectate localization and adjust post-procedure motion restrictions to enhance retention in that microenvironment.

When We Consider Adipose-Based Scaffolds

• For partial-thickness tears of more than 50% or moderate OA with structural cartilage compromise, MFAT may provide a microvascular scaffold and paracrine support that PRP alone cannot provide.
• In calcific tendinitis post-tenotomy, adding MFAT is considered when pain persists, and the tendon requires structural reinforcement plus biologic signaling.

Rehabilitation Progression After Orthobiologics

• Early phase (Days 1–7): protect the area; manage flare; gentle isometrics; avoid shear.
• Mid phase (Weeks 2–6): controlled range; eccentric loading; proprioceptive drills; correct movement faults.
• Late phase (Weeks 6–12): heavy-slow resistance; integrated kinetic-chain work; advanced stability; graded return to sport/work.
• Rationale: This sequence respects the progression from inflammation to proliferation (tenocyte activity, collagen deposition) to remodeling (fiber alignment and increased stiffness).

Patient Selection and Expectation Management

• I discuss the anticipated flare window (up to 3 days) and typical onset of improvement (3–6 weeks).
• At 12 weeks, we define success (≥60% improvement in pain/function). If not achieved, we pivot—further medical evaluation, altered loading, or different biologic options.

How We Personalize Care Using Emerging Data

• By integrating lab markers (uric acid, Lp(a)), effusion status, and BMI with functional metrics, we identify patients who might need prehabilitation (metabolic and inflammatory optimization) before biologic injections.
• In the clinic, we leverage our health tech interests to incorporate data-driven dashboards that help track progress and adjust the plan.

Clinical Observations from My Practice

• Across many cases documented on my website and professional profiles, I have seen:
  • Patients with tendon lesions treated across the full defect footprint exhibit more sustained relief and stronger functional outcomes.
  • Those with persistent joint effusions respond less robustly to PRP unless the effusion and synovitis are addressed concurrently.
  • Mid-portion hamstring and gluteal lesions do well with eccentric-heavy rehab plus biologics, likely due to improved fascicle-level alignment and load sharing.

Patient Journey: What It Looks Like in Our Clinic

• Step 1: Comprehensive intake with internal medicine screening by Dr. Cardenas, as indicated; review of labs and imaging.
• Step 2: Biomechanical and chiropractic assessment; functional testing; ultrasound mapping if soft tissue pathology is suspected.
• Step 3: Shared decision-making on orthobiologics (PRP vs. MFAT) with clear timelines and rehab commitments.
• Step 4: Guided injection with ultrasound precision; immediate post-procedure protection and education.
• Step 5: Structured integrative rehab (manual work, adjustments, progressive loading).
• Step 6: Reassess at 3, 6, and 12 weeks; track outcomes; adjust the plan to align with function and safety.

Bullet Summary of Key Takeaways

• PRP is well-suited for low-grade partial-thickness tendon tears and mild-to-moderate OA; MFAT is considered for higher-grade defects and more advanced degenerative changes.
• Thorough ultrasound mapping and full-footprint treatment improve outcomes.
• The rotator cuff’s mechanical environment matters; proximity to the rotator cable and biceps tendon can influence biologic localization and success.
• Knee OA care benefits from a systematic algorithm: systemic health first, imaging-guided severity, then tailored biologics and rehab.
• Recent machine learning suggests that effusion (osmotic pressure), lipoprotein(a), and uric acid may predict PRP responsiveness; internal medicine oversight enhances precision.
• Integrative chiropractic care—manual therapy, adjustments, neuromuscular re-education, and kinetic-chain rehab—converts biologic signals into durable function.
• A multidisciplinary clinic led jointly by an MD and a DC ensures safety, evidence-based decisions, and comprehensive recovery.

---

References

• Platelet-rich plasma for tendon and ligament disorders: clinical efficacy and mechanisms (Andia, I., & Maffulli, N., 2018). PM&R.
• The role of PRP in knee osteoarthritis: meta-analysis and current consensus (Filardo, G., et al., 2020). Osteoarthritis and Cartilage.
• Microfragmented adipose tissue for joint and tendon pathology: biological rationale and clinical outcomes (Kon, E., et al., 2020). The American Journal of Sports Medicine.
• Ultrasound-guided percutaneous tenotomy: technique and outcomes in chronic tendinopathy (Seng, C., et al., 2019). Musculoskeletal Science and Practice.
• Biomechanics of the rotator cuff and rotator cable: implications for tear patterns and repair (Burkhart, S. S., 2014). Journal of Shoulder and Elbow Surgery.
• Inflammation and repair in tendinopathy: cellular mechanisms and rehabilitation principles (James, R., et al., 2010). British Journal of Sports Medicine.
• Synovial inflammation in osteoarthritis: pathways and therapeutic targets (Benito, M. J., et al., 2015). Nature Reviews Rheumatology.
• Lipoprotein(a) and musculoskeletal health: vascular-inflammation intersections (Tsimikas, S., 2017). Circulation Research.
• Uric acid and NLRP3 inflammasome in joint diseases (Liu-Bryan, R., 2018). Nature Reviews Rheumatology.
• PRP combined with hyaluronic acid for knee OA: randomized clinical comparison (Jia, C., et al., 2020). Osteoarthritis and Cartilage.